Forte Biosciences ( FBRX ) has initiated an underwritten public offering of common stock. The company may grant underwriters a 30-day option to buy up to an additional 15% of shares. Proceeds will be used for working capital, clinical development, and research activities. More on Forte Biosciences Forte Biosciences GAAP EPS of -$4.71 Seeking Alpha’s Quant Rating on Forte Biosciences Historical ear...
Forte Biosciences ( FBRX ) has initiated an underwritten public offering of common stock. The company may grant underwriters a 30-day option to buy up to an additional 15% of shares. Proceeds will be used for working capital, clinical development, and research activities. More on Forte Biosciences Forte Biosciences GAAP EPS of -$4.71 Seeking Alpha’s Quant Rating on Forte Biosciences Historical earnings data for Forte Biosciences Financial information for Forte Biosciences
ROCHESTER, N.Y., April 08, 2026 (GLOBE NEWSWIRE) -- Constellation Brands, Inc. (NYSE: STZ), a leading beverage alcohol company, reported today its full fiscal year and fourth quarter 2026 financial results. A conference call to discuss the financial results and outlook will be hosted by President and Chief Executive Officer, Bill Newlands, and Executive Vice President and Chief Financial Officer, ...
ROCHESTER, N.Y., April 08, 2026 (GLOBE NEWSWIRE) -- Constellation Brands, Inc. (NYSE: STZ), a leading beverage alcohol company, reported today its full fiscal year and fourth quarter 2026 financial results. A conference call to discuss the financial results and outlook will be hosted by President and Chief Executive Officer, Bill Newlands, and Executive Vice President and Chief Financial Officer, Garth Hankinson, on Thursday, April 9, 2026, at 8:00 a.m. ET. Incoming President and CEO Nicholas Fink will also join at the beginning of the call to provide brief remarks before turning the call over to Mr. Newlands and Mr. Hankinson to conduct the question-and-answer session. Visit ir.cbrands.com to locate information for joining the conference call, or a live, listen-only webcast of the conference call.
DALLAS, April 08, 2026 (GLOBE NEWSWIRE) -- Applied Digital Corporation (Nasdaq: APLD) (“Applied Digital” or the “Company”) , a designer, builder, and operator of high-performance, sustainably engineered data centers and colocation services for artificial intelligence, cloud, networking and blockchain workloads, reported financial results for the fiscal third quarter ended February 28, 2026. The Co...
DALLAS, April 08, 2026 (GLOBE NEWSWIRE) -- Applied Digital Corporation (Nasdaq: APLD) (“Applied Digital” or the “Company”) , a designer, builder, and operator of high-performance, sustainably engineered data centers and colocation services for artificial intelligence, cloud, networking and blockchain workloads, reported financial results for the fiscal third quarter ended February 28, 2026. The Company also provided operational updates.
PriceSmart press release ( PSMT ): Q2 GAAP EPS of $1.62 beats by $0.06 . Revenue of $1.50B (+10.3% Y/Y) beats by $20M . Adjusted EBITDA for the second quarter of fiscal year 2026 was $99.7 million compared to $87.0 million in the same period last year. More on PriceSmart PriceSmart's Discount Is Disappearing, But Not Gone Yet PriceSmart Q2 2026 Earnings Preview Quant snapshot: Delta Air Lines lead...
PriceSmart press release ( PSMT ): Q2 GAAP EPS of $1.62 beats by $0.06 . Revenue of $1.50B (+10.3% Y/Y) beats by $20M . Adjusted EBITDA for the second quarter of fiscal year 2026 was $99.7 million compared to $87.0 million in the same period last year. More on PriceSmart PriceSmart's Discount Is Disappearing, But Not Gone Yet PriceSmart Q2 2026 Earnings Preview Quant snapshot: Delta Air Lines leads top-rated names as Byrna Technologies, Simulations Plus lag Seeking Alpha’s Quant Rating on PriceSmart Historical earnings data for PriceSmart
Oracle Corporation (NYSE: ORCL) has received notice of an unsolicited mini-tender offer by TRC Capital Investment Corporation (TRC) dated March 24, 2026, to purchase up to 1,000,000 shares of Oracle's common stock at a price of $140.50 per share in cash. The offer represents less than 0.04% of Oracle's outstanding common stock.
Oracle Corporation (NYSE: ORCL) has received notice of an unsolicited mini-tender offer by TRC Capital Investment Corporation (TRC) dated March 24, 2026, to purchase up to 1,000,000 shares of Oracle's common stock at a price of $140.50 per share in cash. The offer represents less than 0.04% of Oracle's outstanding common stock.
Microsoft Health & Life Sciences COO brings expertise in scaling healthcare platforms, commercializing new technologies, and driving operational efficiencyWALTHAM, Mass., April 08, 2026 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, today a...
Microsoft Health & Life Sciences COO brings expertise in scaling healthcare platforms, commercializing new technologies, and driving operational efficiencyWALTHAM, Mass., April 08, 2026 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, today announced the appointment of Mary Varghese Presti to its Board of Directors. The appointment of Vargh
Microsoft Corp. will publish fiscal year 2026 third-quarter financial results after the close of the market on Wednesday, April 29, 2026, on the Microsoft Investor Relations website at https://www.microsoft.com/en-us/Investor/. A live webcast of the earnings conference call will be made available at 2:30 p.m. Pacific Time.
Microsoft Corp. will publish fiscal year 2026 third-quarter financial results after the close of the market on Wednesday, April 29, 2026, on the Microsoft Investor Relations website at https://www.microsoft.com/en-us/Investor/. A live webcast of the earnings conference call will be made available at 2:30 p.m. Pacific Time.
Ark Invest is loading up on CRWV stock, betting that its hyper‑growth AI cloud business, Nvidia partnership, and huge revenue backlog will ultimately outweigh today’s deep losses and heavy leverage.
Ark Invest is loading up on CRWV stock, betting that its hyper‑growth AI cloud business, Nvidia partnership, and huge revenue backlog will ultimately outweigh today’s deep losses and heavy leverage.
UnitedHealth Group ( UNH ) shares snapped six straight sessions of gains on Wednesday, as the stock was 0.5% lower at $306.14. The health care and well-being company gained over 17% in the preceding six sessions. UNH is up 7% over the past one month. Most recently, UNH and fellow healthcare insurance companies gained on the news that the Trump administration will increase average Medicare Advantag...
UnitedHealth Group ( UNH ) shares snapped six straight sessions of gains on Wednesday, as the stock was 0.5% lower at $306.14. The health care and well-being company gained over 17% in the preceding six sessions. UNH is up 7% over the past one month. Most recently, UNH and fellow healthcare insurance companies gained on the news that the Trump administration will increase average Medicare Advantage payments by 2.48%, or more than $13B, in 2027. Looking at Seeking Alpha's Quant Rating, UNH has a Hold rating with a score of 3.3 out of 5. The company received A+ in the prospect of profitability, while it received F in the growth factor. Seeking Alpha analysts are positive and see the stock as a Buy. Turning to the Wall Street , 23 analysts have given the stock a Buy or above rating. Five gave the stock hold recommendation, while one gave Strong Sell rating to UNH. “Even with conservative assumptions, UNH remains undervalued by roughly 10%, making it a market-beating opportunity with a wide margin of safety despite execution and regulatory risks,” pointed out a recent Seeking Alpha analysis. More on UnitedHealth UnitedHealth Group - A Margin Expansion Story UnitedHealth: Quantifying The Impact Of The New CMS Payment Increase UnitedHealth: The CMS Boost Changes Everything Now Managed care rebounds after Medicare rate decision Industry group says health plans have cut 11% of prior authorizations
Laurence Dutton/iStock via Getty Images Thesis I think that the easiest way to think about The Williams Companies, Inc. ( WMB ) is they’re basically a giant toll-road company for natural gas. They usually aren’t the ones drilling the gas out of the ground, and they usually aren’t the utility selling it to your house either. However, they possess the pipes, storage facilities, processing equipment,...
Laurence Dutton/iStock via Getty Images Thesis I think that the easiest way to think about The Williams Companies, Inc. ( WMB ) is they’re basically a giant toll-road company for natural gas. They usually aren’t the ones drilling the gas out of the ground, and they usually aren’t the utility selling it to your house either. However, they possess the pipes, storage facilities, processing equipment, and other infrastructure required to transport natural gas to the areas it is needed including generating stations, LNG export terminals, manufacturing centers, and local utility companies. Their crown jewel is Transco , which is a huge pipeline system running from Texas up to New York City. In addition, they also have gathering and processing facilities located in leading gas-production areas, allowing them to gather raw gas from wellheads, process it for shipment, and deliver it to consumers. A new factor now is power. Williams has begun developing what it calls a “ power innovation business .” In simple terms, it’s using its natural gas supply and turbine know-how to provide electricity solutions for very large energy users, such as data centers. WMB's 6 month performance (TradingView) Recently, WMB’s been on my radar as it broke a key resistance level, up around 20% YTD. This is my first time covering the company, and after going over the most relevant fundamentals and data, I’m leaning neutral given the strong business quality but limited upside at current valuations. The Williams Companies: Power Platform Scaling & Monetization Power innovation total investment : $7.3B Power innovation EBITDA (run-rate by 2029): ~$1.4B Power project capacity (executed PPAs): ~1.3 GW New project (Socrates the Younger): 340 MW, $1.3B Additional project expansion (Aquila & Apollo): +$0.9B Power innovation contract terms: 10–12.5 years Build multiples (power projects): ~5x EBITD. In addition to maintaining the strength of the legacy pipe business during the quarter, another key takeaway ...